Neuroscience
Steven Brem, MD, Professor of Neurosurgery, Chief of the Division of Neurosurgical Oncology and Co-Director of the Penn Brain Tumor Center, has received the first Joel A. Gingras, Jr. award given by the American Brain Tumor Association (ABTA).
- Brain Tumor Symposium: Bridging Precision Science And Personalized Medicine
Penn Medicine’s Abramson Cancer Center and Brain Tumor Center are pleased to host the Penn Oncology Neurosurgery Symposium. Full program overviewWhen:Friday, June 6, 2014 Where:Smilow Center for Translational Research Perelman School of Medicine at...
- Penn Neurosurgery Creates Precise Tumor Classifier For Glioblastoma
A newly developed, more specific approach to classifying tumors by molecular type can help cancer researchers to determine tumor characteristics and guide treatment strategies. Donald O'Rourke, MD A team of researchers from the Perelman School of...
- Focus On Brain Cancer: Discovery To Recovery
The Focus On Brain Cancer: Discovery to Recovery conference is sponsored by the Abramson Cancer Center. The Focus On Brain Cancer conference is for adults who are newly diagnosed, in treatment of survivors of brain cancer. At this conference, adults with...
- Shaping The Future Of Brain Tumor Research
Join some of the top researchers from around the country as they discuss the future of brain tumor research at the Shaping the Future of Brain Tumor Research Event Detailsseminar on Friday, June 21, 2013. This event is sponsored by the Abramson Cancer...
- Delaware Walk Generates Funds For Brain Tumor Research
According to the National Brain Tumor Society, nearly 70,000 new, primary brain tumors will be diagnosed in the U.S. this year alone. Brain tumors can occur in anyone—adults as well as children and almost 700,000 people are living with tumors of the...
Neuroscience
Steven Brem, MD receives American Brain Tumor Association Award
Dr. Brem has performed more than 3,600 brain tumor surgeries, participated in over 100 clinical trials and has conducted extensive research in the discovery and translation of novel inhibitors of angiogenesis and glioma progression. The Penn Brain Tumor Center brings together clinicians and scientists from across Penn Medicine, including Penn Neurosurgery and Penn’s Abramson Cancer Center.
The Joel A. Gingras, Jr. award, launched by the ABTA's Board of Directors in 2010, acknowledges exceptional organizations or individuals making a noteworthy impact on furthering the ABTA’s mission to advance the understanding and treatment of brain tumors. Read more here.
The Penn Brain Tumor Center (BTC) is nationally recognized for innovative, cutting-edge therapy of benign and malignant tumors originating in the brain, as well as metastatic cancer that originates outside of the brain. A collaborative team of Penn specialists work to develop a customized, personalized treatment plan based on a comprehensive, multidisciplinary review of all of the diagnostic information available. This includes molecular profiling, advanced neuroimaging and neurocognitive testing to select the best therapeutic options. The BTC is dedicated to a single mission: from discovery to recovery, the Penn Brain Tumor Center provides a circle of exceptional care for patients with brain tumors.
- Brain Tumor Symposium: Bridging Precision Science And Personalized Medicine
Penn Medicine’s Abramson Cancer Center and Brain Tumor Center are pleased to host the Penn Oncology Neurosurgery Symposium. Full program overviewWhen:Friday, June 6, 2014 Where:Smilow Center for Translational Research Perelman School of Medicine at...
- Penn Neurosurgery Creates Precise Tumor Classifier For Glioblastoma
A newly developed, more specific approach to classifying tumors by molecular type can help cancer researchers to determine tumor characteristics and guide treatment strategies. Donald O'Rourke, MD A team of researchers from the Perelman School of...
- Focus On Brain Cancer: Discovery To Recovery
The Focus On Brain Cancer: Discovery to Recovery conference is sponsored by the Abramson Cancer Center. The Focus On Brain Cancer conference is for adults who are newly diagnosed, in treatment of survivors of brain cancer. At this conference, adults with...
- Shaping The Future Of Brain Tumor Research
Join some of the top researchers from around the country as they discuss the future of brain tumor research at the Shaping the Future of Brain Tumor Research Event Detailsseminar on Friday, June 21, 2013. This event is sponsored by the Abramson Cancer...
- Delaware Walk Generates Funds For Brain Tumor Research
According to the National Brain Tumor Society, nearly 70,000 new, primary brain tumors will be diagnosed in the U.S. this year alone. Brain tumors can occur in anyone—adults as well as children and almost 700,000 people are living with tumors of the...